Label

How We Work

Grant

Back

Print

University of North Carolina at Chapel Hill


April 2006
to conduct Phase III trials and obtain regulatory approval for an oral drug for early stage African sleeping sickness
$16,786,971
98
Neglected Tropical Diseases
GLOBAL|AFRICA
Global Health
Chapel Hill, North Carolina
http://www.unc.edu

Visit Our Blog